# How Should Clinics Use Value-Based Care Risk Forecasting in 2026?

getpulse.care · September 30, 2026

> How Clinics Should Use Value-Based Care Risk Forecasting in 2026 Value-based care risk forecasting should be used as an operational coordination tool...

## How Clinics Should Use Value-Based Care Risk Forecasting in 2026

Value-based care risk forecasting should be used as an operational coordination tool, not as a mechanism for labeling patients “expensive.” Clinics and care networks need to estimate which patients, physician panels, or service lines are likely to experience avoidable utilization, poor outcomes, missed care opportunities, or financial losses under a value-based contract, and then connect those predictions to a defined intervention. In 2026, the strongest programs will combine claims, electronic health records, utilization data, care-gap information, and patient-reported signals with human review. They will measure whether a forecast led to a timely action and a measurable improvement, rather than treating a model score as the outcome itself.

**Also worth reading:** [What Is a B2B Care Coordination Platform for Clinics and Care Networks?](https://getpulse.care/knowledge/what_is_a_b2b_care_coordination_platform_for_clinics_and_care_networks-3.php) · [Which RPM dashboard metrics should clinics track to manage care and patient engagement?](https://getpulse.care/knowledge/which_rpm_dashboard_metrics_should_clinics_track_to_manage_care_and_patient_engagement.php) · [How Can Care Network Software Prove ROI for Clinics and Health Systems?](https://getpulse.care/knowledge/how_can_care_network_software_prove_roi_for_clinics_and_health_systems.php)

The distinction matters because risk is not the same as cost. A patient may be clinically complex but well managed, while another patient with moderate predicted spending may have several untreated conditions that could lead to an emergency visit. Forecasting should therefore examine multiple dimensions: probability of hospitalization or readmission, likelihood of high-cost care, disease progression, adherence barriers, unmet social needs, and the possibility that appropriate treatment can reduce risk. A Cedar Gate survey, reported by HIT Consultant, found that 83% of health plans miss value-based-care outcomes because they cannot connect data from different organizations. That fragmentation makes it harder to identify the factors behind a predicted event and harder to know whether an intervention is working.

## What Value-Based Care Risk Forecasting Actually Measures

Value-based care risk forecasting estimates future conditions, events, or performance under a payment arrangement. A model might estimate the probability that a patient will be admitted within 30 or 90 days, that a physician panel will exceed its total-cost-of-care benchmark, or that a service line will experience an avoidable readmission. It can also identify patients likely to miss preventive care, diabetes control, or post-discharge follow-up. The useful output is not simply “high risk.” It is a probability, a time horizon, an explanation of contributing factors, and a recommended next action.

Forecasting differs from retrospective risk adjustment. Risk adjustment often explains expected costs for a population using diagnoses and demographic factors, whereas forecasting is intended to support decisions before an event occurs. Predictive models may estimate the risk of an admission, but a clinic still needs to determine whether outreach, medication reconciliation, a behavioral-health referral, or a same-day appointment is appropriate. The model should be treated as a prioritization signal. Clinicians and care coordinators must assess whether the predicted risk is actionable, whether the patient agrees to the proposed intervention, and whether the intervention is likely to improve outcomes rather than simply reduce spending.

Uncertainty is unavoidable. Claims can be delayed, diagnoses can be coded inconsistently, and a patient’s circumstances can change after a model is run. A credible system should show confidence intervals or calibration information, identify when data are stale, and avoid presenting probabilistic predictions as certainties. In 2026, clinics should demand transparent model performance by population and use case. A model that performs well overall may perform poorly for rural patients, patients with disabilities, multilingual patients, or communities with sparse data. Fairness monitoring is therefore part of risk forecasting, not an optional technical refinement.

## Why 2026 Is Different for Clinics and Care Networks

Several forces are making forecasting more important, but none eliminates the need for clinical judgment. Value-based payment arrangements increasingly expose providers to the total cost and quality of care across settings, not just the services delivered inside one clinic. Hospitals and health systems face pressure from rising operating costs, changing enrollment, and contract benchmarks that may not keep pace with clinical inflation. HealthLeaders Media has reported on rising financial risk associated with falling ACA enrollment, while market forecasts continue to project substantial growth in value-based healthcare services. Clinics that cannot distinguish random cost variation from preventable risk may respond by reducing services instead of improving coordination.

At the same time, data availability is improving. Electronic health records, claims feeds, pharmacy information, remote-monitoring data, and patient-generated signals can provide a more complete picture of risk than any single source. However, more data can also create more noise. A platform may ingest thousands of variables without knowing which ones are reliable, current, or relevant to the decision at hand. The practical advantage belongs to organizations that connect data to a workflow: a risk signal should appear in a work queue, include an owner, and have a deadline. A dashboard that merely displays a ranked list of patients is less likely to change care than a system that routes an actionable alert to a care manager.

The market for predictive analytics has expanded alongside these needs. Research cited in the context of value-based care emphasizes the role of predictive modeling in identifying high-risk patients and optimizing care plans, while studies in areas such as multiple sclerosis demonstrate how machine-learning models can support risk stratification and cost prediction. Clinics should learn from that research without assuming that an academic model will transfer directly to a local population. In 2026, vendor selection, governance, workflow integration, and performance measurement will matter at least as much as model sophistication.

## Recommended Operating Model for Forecasting

A clinic should begin with a specific decision and a specific population. Instead of “find our highest-risk patients,” it might define a 90-day program for patients with heart failure who have recently been discharged, a 30-day outreach program for patients with uncontrolled diabetes and no primary-care follow-up, or a panel review process for attributed lives approaching a shared-savings benchmark. The population, prediction horizon, intervention, owner, and outcome measure should be recorded before a model is selected. This prevents a common mistake: purchasing a broad enterprise-risk platform without determining how its results will be used.

The next step is to assemble data from claims, the EHR, scheduling, pharmacy, care-management records, and relevant nonclinical sources. Data should be matched carefully, because duplicate records and incorrect patient identities can produce both false positives and missed cases. The clinic should also record when each source was updated, because a prediction based on a six-month-old medication list is not equivalent to one based on current information. Social determinants such as transportation, food insecurity, housing instability, or language access may be important, but they should be collected respectfully and used to offer support rather than to restrict care.

The workflow should assign each forecast to a role. A physician may review clinical deterioration signals, while a nurse or community health worker may address medication access or a missed appointment. A care coordinator should receive enough context to understand the contributing factors and communicate with the patient. Every alert needs an escalation path and a disposition: acted, already addressed, unable to contact, clinically inappropriate, or awaiting more information. Without those states, clinics cannot distinguish a true negative from a failure of outreach or a poorly designed process.

| Forecasting Use | Typical Decision | Data Needed | Primary Owner | Success Measure |
| --- | --- | --- | --- | --- |
| 30-day readmission risk | Post-discharge outreach and follow-up | Claims, EHR, medications, visit history | Care manager or nurse | Follow-up completion and reduced avoidable admissions |
| 90-day utilization risk | Panel management and capacity planning | Claims, utilization, care gaps, demographic context | Clinic operations and care coordination | Fewer avoidable emergency visits and better panel performance |
| Chronic-disease deterioration | Medication, lab, and appointment intervention | EHR, laboratory, pharmacy, remote monitoring | Clinician and care team | Improved control and fewer acute escalations |
| Missed-care opportunity | Preventive or follow-up outreach | Care-gap data, eligibility, patient contact history | Nurse, outreach team, or primary care | Gap closure without unnecessary visits |
| Panel financial risk | Contract review and resource allocation | Total-cost-of-care, quality, utilization, contract terms | Network leader and finance | Risk-adjusted quality and appropriate utilization |

## How to Act on a Forecast Without Causing Harm
A forecast should trigger a proportionate response. A moderate-risk signal may justify reviewing the chart or sending a questionnaire, while a high-confidence, near-term signal may warrant same-day clinical outreach. The intervention should match the problem. A patient with transportation barriers may need a telehealth option; a patient with an unstable medication regimen may need a pharmacist call; a patient who has already received appropriate care may need no further intervention. The objective is not to maximize the number of patients contacted. It is to identify people for whom timely, acceptable action could improve outcomes or reduce avoidable utilization.

Risk scores should not be used to deny access, discharge patients, reduce coverage, or assume that a patient is responsible for poor outcomes. Such uses can worsen inequity and damage trust. Patients should receive an understandable explanation of why the clinic is reaching out and should be involved in decisions about their care. If a prediction relies on race, socioeconomic status, disability, language, or geography, the clinic should test whether those variables are improving prediction fairly or simply reproducing historical disparities. A model can identify correlation, but it cannot determine whether a person will benefit from an intervention.

The timing of action is as important as the score. Forecasting a hospitalization 30 days out is useful only if the clinic has enough time to review medications, confirm transportation, arrange follow-up, and address social barriers. A 24-hour prediction may be useful for staffing and escalation, but it may be too late for many preventive interventions. Clinics should define “when to act” in terms of operational windows. A useful rule might be to review high-priority post-discharge signals within 24 hours, complete patient outreach within 48 hours, and document the resulting plan within 72 hours. These are workflow thresholds, not universal clinical standards, and should be adapted to the condition and available staff.

## Comparing Risk Scores, Cost Forecasts, and Quality Measures

Risk scores, cost forecasts, and quality measures answer different questions. A patient-level risk score estimates the likelihood of an event or outcome. A cost forecast estimates the resources and spending likely to be required over a defined period. A quality measure evaluates whether care met a clinical or process standard. They may be related, but they should not be collapsed into a single number. Combining them too early can hide whether a patient is expensive because of appropriate treatment, poor access, or a serious illness that the organization has not yet addressed.

A clinic may be tempted to use predicted cost as the primary prioritization tool because contracts create financial accountability. That can be misleading. Spending may rise when a clinic appropriately identifies previously untreated disease, performs a needed procedure, or responds to an emerging outbreak. Conversely, low spending may reflect missed care rather than good outcomes. Forecasting should be paired with quality measures such as preventive-care completion, disease-control indicators, medication safety, patient experience, and equity measures. Financial performance should be evaluated alongside those measures, not substituted for them.

Predictive accuracy also depends on the comparison being made. A model may outperform a simple rule-based outreach program on average while performing worse for a particular subgroup. Clinics should compare the tool with existing workflows and with a “do nothing” baseline, while also considering staff time and patient burden. A modest improvement in prediction may not justify a costly platform if the clinic already identifies most high-risk patients through care-management experience. Conversely, a model that improves targeting may be valuable if it reduces unnecessary outreach, identifies overlooked patients, or helps distribute scarce staff more consistently.

## Common Mistakes and Governance Requirements

The most common mistake is treating a forecast as a diagnosis. A prediction that a patient is likely to use the emergency department does not explain why, and it does not establish that emergency-department use is preventable. Another mistake is assuming that more variables automatically produce a better model. Data quality, missingness, leakage, and local changes in care patterns can be more consequential than the number of features. Clinics should test models prospectively, monitor calibration after deployment, and suspend or revise them when performance drifts.

Another error is measuring success only by total spending or hospital admissions. An outreach program may reduce admissions while worsening patient experience, shifting work to caregivers, or delaying needed care. It may also fail to reach the patients with the greatest barriers. Organizations should report intervention reach, time to action, clinical outcomes, utilization, patient-reported outcomes, and equity. This requires a data-governance process that identifies permitted uses, access rights, retention periods, and accountability for incorrect predictions.

Vendor contracts should clarify who owns the data, whether derived data can be used for other customers, how models are validated, what happens when performance declines, and whether the vendor will provide interpretable explanations. Health systems should also determine whether the tool is intended for clinical decision support, operational planning, financial analysis, or all three. A system that is acceptable for forecasting panel-level budget risk may not be appropriate for making individual clinical decisions. Governance should include clinicians, data specialists, finance leaders, compliance representatives, and patient or community representatives.

## When Clinics Should Act, Pilot, or Wait

Clinics should act when the decision is clearly defined, the data are sufficiently current, and the predicted risk creates a realistic opportunity to help. Strong initial use cases include post-discharge coordination, chronic-disease management, high-risk medication review, and identifying patients with avoidable missed care. These are situations in which a prediction can be linked to an established intervention and measured within weeks or months. For example, a heart-failure program could combine recent discharge, medication changes, weight monitoring, and follow-up status to prioritize outreach. The model should then be evaluated against the program’s normal process.

Clinics should pilot before expanding when the outcome is uncertain, the population is heterogeneous, or the model’s local performance is unknown. A pilot should have a comparison group or a staggered rollout where feasible, and it should preserve a way to distinguish model effects from broader quality-improvement efforts. The pilot should also include a plan for staff training and patient communication. If the platform identifies potential risk but care teams lack time to respond, the organization is not ready to deploy it broadly.

Waiting may be appropriate when a contract or regulatory environment is unstable, the data are unreliable, or the proposed action could create harm. Clinics should not purchase a forecast merely because a vendor describes it as AI-powered or because competitors appear to be adopting it. They should first ask whether the forecast improves a decision, whether the organization can act on the result, and whether it can measure the result fairly. In 2026, the practical question is not whether a clinic can predict risk. It is whether the clinic can turn a calibrated, timely, and equitable prediction into better care without imposing unnecessary burden on patients or clinicians.

Canonical: https://getpulse.care/knowledge/how_should_clinics_use_value-based_care_risk_forecasting_in_2026.php
Markdown: https://getpulse.care/knowledge/how_should_clinics_use_value-based_care_risk_forecasting_in_2026.php/index.md